Abstract:Within the realm of contemporary medicinal chemistry, bioisosteres are empirically used to enhance potency and selectivity, improve adsorption, distribution, metabolism, excretion and toxicity profiles of drug candidates. It is believed that bioisosteric know-how may help bypass granted patents or generate novel intellectual property for commercialization. Beside the synthetic expertise, the drug discovery process also depends on efficient in silico tools. We hereby present BioisoIdentifier (BII), a web server aiming to uncover bioisosteric information for specific fragment. Using the Protein Data Bank as source, and specific substructures that the user attempt to surrogate as input, BII tries to find suitable fragments that fit well within the local protein active site. BII is a powerful computational tool that offers the ligand design ideas for bioisosteric replacing. For the validation of BII, catechol is conceived as model fragment attempted to be replaced, and many ideas are successfully offered. These outputs are hierarchically grouped according to structural similarity, and clustered based on unsupervised machine learning algorithms. In summary, we constructed a user-friendly interface to enable the viewing of top-ranking molecules for further experimental exploration. This makes BII a highly valuable tool for drug discovery. The BII web server is freely available to researchers and can be accessed at http://www.aifordrugs.cn/index/. Scientific Contribution: By designing a more optimal computational process for mining bioisosteric replacements from the publicly accessible PDB database, then deployed on a web server for throughly free access for researchers. Additionally, machine learning methods are applied to cluster the bioisosteric replacements searched by the platform, making a scientific contribution to facilitate chemists' selection of appropriate bioisosteric replacements. The number of bioisosteric replacements obtained using BII is significantly larger than the currently available platforms, which expanding the search space for effective local structural replacements.

Identified Isosteric Replacements of Ligands' Glycosyl Domain by Data Mining

BioisoIdentifier: an online free tool to investigate local structural replacements from PDB

Pharmacophore Fingerprint-Based Approach to Binding Site Subpocket Similarity and Its Application to Bioisostere Replacement

Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization

Computer Modeling for Interaction of Ligands and Receptors and Their Applications in Drug Design

Orthologue chemical space and its influence on target prediction

Rag2Mol: Structure-based drug design based on Retrieval Augmented Generation

Identifying ligand binding sites and poses using GPU-accelerated Hamiltonian replica exchange molecular dynamics

Scaffold-Hopped Compound Identification by Ligand-Based Approaches with a Prospective Affinity Test

A Practical Guide to Molecular Docking and Homology Modelling for Medicinal Chemists

Improving Measures of Chemical Structural Similarity Using Machine Learning on Chemical-Genetic Interactions

Identification of specificity determining residues in enzymes using environment specific substitution tables

Direct Bioisostere Replacement Enabled by Metallaphotoredox Deoxydifluoromethylation

The Application of in Silico Drug-Likeness Predictions in Pharmaceutical Research.

Quantum Mechanical-Cluster Approach to Solve the Bioisosteric Replacement Problem in Drug Design

Current Advances in Ligand‐based Target Prediction

Binding Selectivity Analysis from Alchemical Receptor Hopping and Swapping Free Energy Calculations

Computational structural-based GPCR optimization for user-defined ligand: Implications for the development of biosensors

Genome-wide Prediction of Small Molecule Binding to Remote Orphan Proteins Using Distilled Sequence Alignment Embedding

A molecular representation to identify isofunctional molecules

Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved Drugs